Vegzelma 100 mg

VEGZELMA 100 MG is a solution for intravenous use containing bevacizumab. It is used to treat certain types of cancer and may help slow the growth of abnormal blood vessels.

VEGZELMA 100 MG is primarily used in cancer treatment. It works by targeting specific proteins involved in the formation of blood vessels that supply tumors. This medication is often used in combination with other treatments to manage various types of cancer, including colorectal, lung, and kidney cancers. Patients should consult their healthcare provider to determine if VEGZELMA 100 MG is suitable for their condition.

Common effects of VEGZELMA 100 MG may include fatigue, high blood pressure, and diarrhea. Some patients might experience more severe side effects such as bleeding or wound healing problems. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

VEGZELMA 100 MG should be handled with care and administered by a healthcare professional. Patients should inform their doctor about any existing medical conditions or allergies before starting treatment. Regular monitoring may be required to manage potential side effects and ensure the medication's effectiveness.

VEGZELMA 100 MG may interact with other medications, including those that affect blood clotting or wound healing. Patients should avoid taking it with certain pain relievers or anti-inflammatory drugs without medical advice. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.